Somerset Indus Capital Partners makes investment in Natural Capsules’ arm

22 Jun 2023 Evaluate

Somerset Indus Capital Partners has invested around Rs 75 crore at a pre-money valuation of Rs 250 crore in Natural Capsules’ unlisted subsidiary -- Natural BioGenex (NBPL). As a result of this transaction, Somerset will hold a stake of between 23% and 28% in NBPL, underscoring their confidence in the company's growth potential and long-term success. 

NBPL is constructing a state-of-the-art Greenfield facility in Tumkur, near Bengaluru. This state-of-the-art plant will manufacture active pharmaceutical ingredients (APIs), including Betamethasone, Dexamethasone, and Prednisolone, along with their intermediates and derivatives. The facility will not only enhance India's self-reliance in the API manufacturing sector but also contribute to the reduction of import dependency, particularly from China.

Natural Capsules is a well-equipped modern manufacturing plant to manufacture hard gelatin capsule shells, Hard cellulose capsule shells and pharmaceutical dosage forms in capsule dosage form.

Natural Capsules Share Price

223.20 -1.55 (-0.69%)
23-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1788.90
Dr. Reddys Lab 1185.95
Cipla 1533.55
Lupin 2088.85
Zydus Lifesciences 868.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...